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Abstract:  EspC and Pet are toxins secreted by the diarrheagenic enteropathogenic and 
enteroaggregative Escherichia coli pathotypes, respectively. Both toxins have a molecular 
mass  around  110  kDa  and  belong  to  the  same  protein  family  called  Serine  Protease 
Autotransporters of the Enterobacteriaceae (SPATE). Furthermore, both toxins act within 
the  cytosol  of  intoxicated  epithelial  cells  to  disrupt  the  architecture  of  the  actin 
cytoskeleton.  This  cytopathic  and  enterotoxic  effect  results  from  toxin  cleavage  of  the 
actin-binding protein fodrin, although the two toxins recognize different cleavage sites on 
fodrin. EspC and Pet also have dramatically different mechanisms of entering the target 
cell  which  appear  dependent  upon  the  E.  coli  pathotype.  In  this  review,  we 
compare/contrast EspC and Pet in regards to their mode of delivery into the target cell, 
their  effects  on  fodrin  and  the  actin  cytoskeleton,  and  their  possible  effects  on  the 
physiology of the intestinal epithelial cell.  
Keywords:  enterotoxins;  autotransporter  proteins;  actin  cytoskeleton;  diarrheagenic  E. 
coli; serine proteases 
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1. Introduction 
Diarrheagenic Escherichia  coli  have  been  loosely classified  into six  major  categories  based on 
clinical associations, serotyping, phenotypic assays, and identification of virulence characteristics. The 
six pathotypes are enteroaggregative E. coli (EAEC), enteropathogenic E. coli (EPEC), enterotoxigenic 
E.  coli  (ETEC),  enterohemorragic  E.  coli  (EHEC),  enteroinvasive  E.  coli  (EIEC),  and  diffusely 
adherent E. coli (DAEC) [1,2]. EAEC and EPEC each produce a distinct serine protease enterotoxin: 
EAEC secretes plasmid-encoded toxin (Pet), while EPEC releases E. coli secreted protein C (EspC). 
Pet and EspC are both Serine Protease Autotransporters of the Enterobacteriaceae (SPATEs) that 
generate diarrheagenic effects through alterations of the actin cytoskeleton. Despite these similarities, 
Pet and EspC exhibit distinct host-toxin interactions and may play different roles in pathogenesis. 
2. EAEC and EPEC Infections 
EAEC infections occur worldwide in both developed and developing countries [3,4]. Children and 
adults living in developed countries are susceptible to acute infection with EAEC, as are travelers 
visiting  developing  countries.  Persistent  EAEC  infections  occur  in  HIV-infected  individuals  and 
children from developing countries. Mucosal damage resulting from EAEC infection has been detected 
in patients, animal models, and in vitro organ culture [5–10]. 
A defining feature of EAEC is its aggregative or “stacked brick” pattern of adherence to intestinal 
tissue and cultured epithelial cells [9–11]. This aggregative adherence (AA) phenotype is derived from 
the ability of EAEC to attach to other EAEC, to epithelial cells, and to the surface of tissue culture 
plates. Adherence involves AA fimbriae expressed from a  65-MDa plasmid (pAA) [12,13]. Upon 
adhesion to the epithelium, EAEC forms a biofilm and induces the production of a thick mucus layer 
over the intestinal surface. The release of toxins into the gut further contributes to enterotoxicity [3,4]. 
One such toxin is Pet, a SPATE encoded on the pAA plasmid [14].  
EPEC  is  a  leading  cause  of  acute  infantile  diarrhea  in  developing  countries  [1].  The  pathogen 
adheres  to  epithelial  cells  on  an  actin-rich  pedestal,  which  replaces  the  intestinal  microvilli.  This 
structure, known as the attaching and effacing (A/E) lesion, reduces the absorptive capacity of the 
intestine and can be detected in patients, animal models, and cell culture [15–19]. The A/E lesion 
results from the injection of bacterial effector proteins into the host cell cytosol through a type III 
secretion system [20]. Effector proteins, as well as the type III secretion apparatus, are encoded within 
a 35.6kilobase (kb) pathogenicity island termed the locus of enterocyte effacement (LEE) [21,22]. A 
second chromosomal pathogenicity island encodes EspC, a SPATE enterotoxin released by the type V 
secretion system [23,24]. Ler, a transcriptional activator encoded in the LEE, couples the expression of 
EspC with the expression of LEE virulence factors [25,26].  
3. Structure of Pet and EspC 
Pet  and  EspC  belong  to  the  SPATE  subfamily  of  autotransporters  [27,28].  SPATEs  and  other 
autotransporters  use  a  type  V  secretion  system  for  export  to  the  extracellular  space  [29,30].  This 
process is thought to be a self-contained event in which the amino acid sequence of the autotransporter 
contains all of the information necessary for passage through the inner membrane as well as the outer Toxins 2010, 2                         
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membrane. To mediate its own secretion, an autotransporter contains three functional domains: an  
N-terminal leader sequence, an extracellular passenger domain, and a C-terminal β-barrel domain. The 
N-terminal  leader  sequence  initiates  Sec-dependent  transport  across  the  inner  membrane  and  is 
proteolytically removed in the periplasmic space. The C-terminal domain forms a β-barrel pore in the 
outer membrane which facilitates delivery of the passenger domain to the extracellular space. The 
passenger domains of some autotransporters remain anchored to the extracellular face of the outer 
membrane, but SPATEs are released from the bacterial cell by proteolytic nicking of a site between the 
β-barrel pore and the passenger domain (Figure 1). The mature, secreted SPATEs are 104–110 kDa 
toxins  that  contain  a  typical  N-terminal  serine  protease  catalytic  domain  followed  by  a  highly
 
conserved β-helix motif, which is present in nearly all autotransporters [27–30]. Although the general 
process of SPATE secretion is understood, the details of many events in SPATE biogenesis (chaperone 
function in the periplasm; mechanism of -barrel insertion into the outer membrane; translocation 
pathway  across  the  outer  membrane;  proteolytic  release  of  the  mature  protein  from  the  outer 
membrane; etc.) remain unresolved.  
Pet and EspC share a similar structural organization. In silico analysis indicated that the Pet leader 
sequence is cleaved between residues A
52 and A
53, while the cleavage site linking the β-domain to the 
mature Pet protein occurs between residues N
1018 and N
1019 [14]. The secreted Pet passenger domain is 
thus a 104 kDa toxin that encompasses amino acid residues 53 to 1018 of nascent Pet. In the case of 
EspC, the leader sequence extends from amino acids 1 to 53; the 110 kDa passenger domain extends 
from amino acids 54 to 1,030; and the β-barrel pore extends from amino acids 1,031 to 1,306 [31]. The 
serine protease motifs of Pet (GDSGS
260G) and EspC (GDSGS
256G) are identical but differ slightly 
regarding the location of the active site serine residue within the passenger domain. Although some 
secreted autotransporters mediate their own proteolytic release from the bacterial surface, neither Pet 
nor EspC required a functional serine protease motif for secretion [23,32]. The proteolytic event which 
releases both toxins is likely mediated by an outer membrane protease or proteases. However, the 
protease(s) responsible for release from the outer membrane has not yet been identified. Identification 
and characterization of the responsible protease(s) would significantly advance our understanding of 
the type V secretion system for SPATE proteins. 
Interestingly, correct folding of the Pet passenger domain appears to require a currently unidentified 
host-specific accessory factor [33]. A substantial fraction of Pet secreted from a HB101 lab strain of  
E. coli transformed with the minimal Pet clone pCEFN1 [14] was detected in a misfolded, inactive 
conformation. The misfolded variant of Pet was not produced by EAEC and did not result from protein 
overproduction in the lab strain of E. coli. This report was consistent with a developing model of 
autotransporter biogenesis in which accessory factors are necessary for the folding and/or secretion of 
an  autotransporter  [34–38].  The  folding  efficiency  of  EspC  has  not  yet  been  examined,  but  the 
extended regions of SPATE surface hydrophobicity predicted from computer modeling suggests that 
efficient, proper folding of EspC and other SPATEs may also require host accessory factors [33]. 
These factors could further assist SPATE biogenesis by (i) facilitating -barrel insertion into the outer 
membrane; (ii) maintaining the passenger domain in a translocation-competent state for movement 
across the outer membrane; and (iii) protecting the nascent passenger domain from degradation by 
periplasmic  proteases.  The  emerging  role  of  chaperones  and  other  accessory  factors  in  SPATE 
biogenesis calls into question the "autotransporter" label for this family of proteins. However, the Toxins 2010, 2                         
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realization  that  chaperone-mediated  events  function  in  autotransporter  secretion  has  consequently 
identified new pharmacological targets to possibly block the release of virulence factors by the type V 
secretion system.  
In  addition  to  Pet  and  EspC,  SPATE  family  members  include  SigA
  and  SepA  from  Shigella 
flexneri, Sat from DAEC and uropathogenic E. coli, Pic from EAEC and Shigella strains, EspP from 
EHEC, and Tsh from avian pathogenic E. coli [27,28]. Phylogenetic analysis of the serine protease 
regions which comprise the N-terminal third of SPATE passenger domains has divided SPATE family 
members into two classes [39]. Class I SPATEs are all cytotoxic to epithelial cells. These toxins 
include  Pet,  EspC,  EspP,  SigA,  and  Sat.  Class  II  SPATEs  are  more  diverse
 with  regard  to  toxin 
function, although several are known to cleave
 mucin. Pic, for example, is a chromosomally-encoded 
mucinase [40] that may promote intestinal
 colonization by an unknown mechanism [41]. Besides Pic, 
Class II SPATEs include SepA and Tsh. Phylogenetic analysis has indicated that Pet, EspC, and Sat 
are more closely related to each other than any other known SPATE [39]. Pet and EspC share a  
55% amino acid identity and 70% amino acid similarity overall; within the passenger domain, there is 
49% amino acid identity  [14]. Despite the relatedness of SPATE family members,  the activity of 
SPATEs is diverse and each one of them needs to be characterized as an individual virulence factor in 
the  context  of  each  SPATE-producing  pathogen.  As  discussed  below,  even  two  closely  related 
SPATEs such as Pet and EspC are distinct in many aspects. 
4. Pet and EspC Activity on Epithelial Cells 
Pet  was  originally  identified  as  an  immunogenic  protein  recognized  by  antisera  from  children 
infected  by  EAEC  [8].  Due  to  the  diarrheagenic  nature  of  EAEC,  a  potential  role  for  Pet  as  an 
enterotoxin  was  investigated.  Pet  was  shown  to  increase  short-circuit  currents  (Isc)  and  decrease 
electrical resistance of rat jejunum mounted in Ussing chambers [42]. These effects were accompanied 
by mucosal damage, exfoliation of cells, and development of crypt abscesses. Similar effects had been 
previously observed for in vitro organ culture [9] and T84 cultured epithelial cells [6] exposed to the 
EAEC bacterium. Deletion of the pet gene was reported to lessen the pathogen-induced effects in 
terms of exfoliation and widening of crypt openings [43].  
Epithelial cells exposed to 25 g/mL of purified Pet begin to display phenotypic changes after two 
hours of toxin exposure [32]. A 10 minute toxin exposure to 10 g/mL of Pet followed by a five hour 
incubation  in  the  absence  of  toxin  was  sufficient  for  productive  intoxication.  The  time-  and  
dose-dependent  cytopathic  effects  of  Pet,  which  could  be  detected  by  light  microscopy,  were 
characterized by an initial cell elongation followed by cell rounding and, ultimately, detachment from 
the  substratum.  Cell  rounding  and  release  from  the  substratum  resulted  from  contraction  of  the 
cytoskeleton,  loss  of  actin  stress  fibers,  and  release  of  focal  contacts.  Pet  disruption  of  the  actin 
cytoskeleton required a functional serine protease motif, as its cytopathic activity was inhibited by the 
serine  protease  inhibitor  phenylmethylsulfonyl  fluoride  (PMSF).  Likewise,  an  S260I  active  site 
mutation eliminated the in vitro protease activity and in vivo cytopathic activity of Pet. Collectively, 
these observations indicated that the serine protease activity of Pet is responsible for alterations to the 
actin cytoskeleton which generate cytopathic and enterotoxic effects.  Toxins 2010, 2                         
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EspC was originally isolated from the supernatant of EPEC grown in the presence of epithelial  
cells  [44].  When  applied  to  rat  jejunal  segments  mounted  in  Ussing  chambers,  EspC  generated 
enterotoxic effects that were manifested as rises in short-circuit currents and transepithelial electrical 
potential differences [24]. Yet, in contrast to the demonstrated role of Pet in EAEC pathogenesis, 
deletion of the espC gene did not affect any obvious aspect of EPEC pathogenesis such as formation of 
the  A/E  lesion  [23].  Purified  EspC  also  generated  cytopathic  effects  against  cultured  epithelial  
cells [45]. Like Pet, EspC-induced cell damage resulted from serine protease activity: no cytoskeletal 
alterations were observed in cells co-incubated with EspC and PMSF or in cells exposed to an EspC 
mutant containing an inactivating S256I mutation in the serine protease active site.  
EspC and Pet elicit similar cytopathic effects from cultured cells: both toxins induce contraction of 
the actin cytoskeleton, cell rounding, and detachment from the substratum [32,45]. Internalization into 
the host cell was required for both EspC and Pet to cause their cytopathic effects [45,46]. However, the 
cytoskeletal alterations resulting from EspC intoxication were only evident when the toxin was applied 
at a concentration of 120 g/mL for at least six hours [45]. Pet, in comparison, was effective at lower 
toxin concentrations and after much shorter incubation periods [32,45]. These differences occurred 
even though EspC and Pet share the same serine protease motif and exhibit a 49% amino acid identity 
in the passenger domain [14].  
5. Delivery of Pet and EspC to the Host Cell Cytosol 
The  greater  potency  of  purified  Pet  in  comparison  to  purified  EspC  is  due  to  the  distinct 
mechanisms of toxin delivery to the host cell. Pet is internalized by receptor-mediated endocytosis [47] 
whereas EspC is internalized by a different mechanism that requires EPEC contact with the host cell 
and production of a type III secretion system [31,48]. Thus, in contrast to Pet toxicity assays, the 
experimental  model  of  cell  intoxication  with  purified  EspC  does  not  represent  a  physiological 
internalization mechanism. 
Pet must be internalized to induce a cytopathic effect [46]. The toxin binds to the epithelial plasma 
membrane at 4 °C  but only damages cells after the temperature is raised to 37 °C  for at least two  
hours [32]. Endocytosis is blocked at 4 °C , so the temperature requirement for productive intoxication 
indicated that Pet does not act at the cell surface. Binding to the plasma membrane at 4 °C  further 
suggested that a possible specific surface receptor is recognized by Pet, although this receptor has yet 
to  be  identified.  Further  evidence  for  the  functional  role  of  endocytosis  in  Pet  intoxication  was 
provided by drug- and siRNA-induced disruptions to clathrin-dependent endocytic events [47]. These 
treatments  effectively  blocked  Pet activity against  cultured cells.  In contrast, neither  drug-induced 
disruptions  to  clathrin-independent  endocytosis  nor  siRNA  knockdown  of  caveolae-dependent 
endocytosis inhibited Pet activity against cultured cells. Collectively, these observations mapped a 
clathrin-dependent endocytic route for Pet internalization (Figure 1). 
The two hour time lag between toxin exposure and toxin damage further indicated that multiple 
intracellular  transport  steps  were  required  for  productive  Pet  intoxication.  Indeed,  the  vectorial 
transport of Pet from the cell surface to the endosomes, from the endosomes to the Golgi apparatus, 
and  from  the  Golgi  apparatus  to  the  endoplasmic  reticulum  (ER)  was  recorded  by  confocal  
microscopy [49]. The functional importance of this trafficking pattern was demonstrated with brefeldin Toxins 2010, 2                         
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A, a drug that blocks transport from the endosomes to the Golgi apparatus: cells exposed to brefeldin 
A were resistant to Pet [46]. In the ER, Pet associated with the Sec61p translocon pore before entering 
the cytosol as an intact 104 kDa protein [49]. This translocation event involved the mechanism of  
ER-associated degradation (ERAD), as a subset of mutant CHO cells with aberrant ERAD activity 
were highly resistant to Pet [49]. 
Many AB toxins also exploit ERAD to enter the target cell cytosol [50]. For these toxins, the 
catalytic A subunit dissociates from the cell-binding B subunit in the ER. The dissociated A subunit 
then unfolds and consequently activates ERAD, an endogenous quality control system which removes 
misfolded proteins from the ER by exporting them to the cytosol through Sec61p and/or Derlin-1 
protein-conducting  channels  [51].  ERAD  substrates  are  degraded  in  the  cytosol  by  the  
ubiquitin-proteasome pathway, but the A subunits of ER-translocating toxins lack lysine residues for 
ubiquitin conjugation and thus persist in the cytosol [52]. Pet, the only non-AB toxin known to use the 
ERAD translocation mechanism, does not exhibit the arginine-over-lysine amino acid bias seen in the 
A subunits of ER-translocating toxins [14]. Furthermore, Pet activation of the ERAD system does not 
appear to involve substantial unfolding of the toxin [53]. Whereas toxin A chains actually unfold to 
trigger their ERAD-mediated translocation [54–57], Pet maintains a folded conformation and instead 
masquerades  as  a  misfolded  protein  for  ERAD  processing  [53].  The  partial  solvent  exposure  of 
aromatic  amino  acid  residues  in  the  native  structure  of  Pet  may  facilitate  its  identification  as  a 
misfolded  protein.  The  recognition  of  Pet  as  a  misfolded  protein  was  further  highlighted  by  the 
activation of another ER quality control system, the unfolded protein response, in cells exposed to Pet 
or the inactive S260I Pet mutant [53].  
Pet travels from the cell surface to the ER before exploiting ERAD to enter the cytosol where it 
damages the actin cytoskeleton (Figure 1). These events have been deduced from research using cell 
culture systems and purified Pet. Recent work using EAEC-treated culture cells has added additional, 
physiological  detail to  the  intoxication process  [58]. Pet  secretion by EAEC during  infection was 
inhibited at the transcriptional level by eukaryotic cell culture medium but not by the same medium 
supplemented with tryptone. In the presence of tryptone, EAEC released enough Pet to cause a toxic 
effect. However, toxicity was not observed when cultured cells were exposed to a HB101 lab strain of 
E. coli that was engineered to secrete high levels of Pet. Unlike EAEC, HB101 did not adhere to the 
cultured cells. A ∆pet EAEC strain that could adhere to the epithelial surface lacked toxicity as well. 
These collective observations indicated that Pet-induced toxicity requires an appropriate environment, 
as mimicked by tryptone-containing medium, and bacterial adhesion to the target cells. Enhanced Pet 
secretion in the presence of tryptone could be of clinical relevance for milk-drinking children infected 
with EAEC, as tryptone is a tryptic digest of the milk protein casein.  
The  physiological conditions  relating  to  EspC  intoxication  are  also  important  for  pathogenesis. 
Purified EspC is internalized by a non-specific pinocytic mechanism, does not bind to the plasma 
membrane at 4 °C  (which indicates the absence of a specific surface receptor), and is weakly toxic in 
comparison to purified Pet [48]. In contrast, EspC was efficiently delivered to the host cell cytosol 
when cultured cells were  exposed  to  EPEC [31,48].  EspC was released from EPEC by a  type V 
secretion system and then entered the epithelial cells through the translocon of the EPEC type III 
secretion system [31]. EspC delivery to the host cytosol occurred after just 1 hour during EPEC-host 
cell interaction; this was much faster than the eight hours required for purified EspC to enter the Toxins 2010, 2                         
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cytosol of cultured cells incubated in the absence of EPEC. The EPEC-facilitated translocation of 
EspC could even occur in trans, as the combination of purified EspC and an EPEC ∆espC strain still 
resulted in rapid delivery of EspC to the target cell cytosol. Moreover, EPEC mutants with defective 
type  III  secretion  systems  were  unable  to  translocate  either  endogenous  or  exogenous  EspC  into 
epithelial cells. This showed for the first time the efficient intracellular delivery of an autotransporter 
by the cooperative interactions between type V and type III secretion systems (Figure 1). The need for 
a type III secretion system to mediate EspC translocation into epithelial cells raises the question of how a 
milieu-secreted protein could gain access to the type III translocon for injection into host cells and 
suggests that the translocon apparatus is not a hermetic conduit from bacterial to eukaryotic cytoplasm. 
Despite their structural similarities, Pet and EspC utilize distinct mechanisms to access the host cell 
cytosol. Endocytosed Pet follows an intracellular trafficking and translocation itinerary utilized by 
many  AB  toxins.  In  fact,  Pet  is  the  only  known  non-AB  toxin  to  use  retrograde  trafficking  and  
ERAD-mediated  translocation  to  reach  the  cytosol.  EspC  also  employs  a  unique  translocation 
mechanism  involving  the  coordinated  action  of  type  V  and  type  III  secretion  systems.  The 
pathogenesis of both toxins is affected by the physiological conditions of intoxication, and additional 
studies should further elucidate the influence of the pathogen itself on the intoxication process.  
6. Effect of Pet and EspC on Fodrin and the Actin Cytoskeleton 
After gaining access to the epithelial cytosol, both Pet and EspC target the actin-binding protein 
fodrin  (also  known  as  spectrin)  [45,59].  However,  Pet  and  EspC  modify  fodrin  by  different 
mechanisms. 
Fodrin  is  an  elongated  heterodimer  consisting  of  a  280  kDa    subunit  and  a  246  kDa    
subunit  [60,61].  Two  heterodimers  associate  in  a  head-to-head  orientation  to  form  a  functional 
tetramer. Both fodrin subunits contain multiple copies of a 106 amino acid motif termed the spectrin 
repeat as well as a src homology 3 domain, a pleckstrin homology domain, a calmodulin binding 
domain, and an actin-binding domain. Through these domains, the fodrin tetramer anchors membrane 
lipids and transmembrane proteins to the cortical actin cytoskeleton which lies beneath the plasma 
membrane.  The  interaction  between  fodrin  and  filamentous  actin  provides  a  degree  of  structural 
organization to the actin cytoskeleton which helps the cell withstand mechanical stress. Fodrin is also 
involved in epithelial morphogenesis [62] and, when cleaved in the 11th repetitive unit by calpain or 
caspase-3, apoptotic cell death [63,64].  
Pet  displays  affinity  for  α-fodrin  in  vitro  and  cleaves  epithelial  fodrin  in  vivo  [59,65].  Two 
breakdown  products  of  37  kDa  and  72  kDa  were  generated  from  in  vitro  Pet  activity  against  a 
recombinant GST-tagged construct that contained a 109 kDa fragment of -fodrin representing the 8th 
to the 14th spectrin repeats (codons 809–1529) [59]. This was the first report showing cleavage of  
-fodrin  by  a  bacterial  protease.  Cleavage  occurred  between  residues  M
1198  and  V
1199  within  the 
calmodulin-binding domain of fodrin's 11th repetitive unit (Figure 1). Site-directed mutagenesis of 
these amino acids prevented GST-fodrin degradation by Pet. An inactivating I260S mutation in the Pet 
serine protease motif also prevented the proteolysis of GST-fodrin.  
Pet also cleaves epithelial fodrin in cultured cells [59,65]. In vivo proteolysis of fodrin did not occur 
in the presence of PMSF or with the Pet I260S mutant toxin. Pet activity against fodrin generated a 120 Toxins 2010, 2                         
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kDa breakdown product  which  was  found  in  intracellular aggregates as  membrane  blebs. Loss  of 
fodrin disrupted the structural link between the plasma membrane and the cortical actin cytoskeleton. 
Contraction of the actin cytoskeleton, loss of actin stress fibers, cell rounding, and eventual detachment 
from the substratum resulted from the loss of proper actin architecture. In intestinal epithelial cells, 
fodrin proteolysis may also lead to disassembly of the microvilli: the lower part of the actin filament 
bundle in the microvilli core is anchored and stabilized by a specialized structure which contains a 
dense core of fodrin [66]. Cleavage of -fodrin to a 120 kDa fragment has been detected in apoptotic 
cells [63,64], so Pet activity may contribute to enterocyte death by triggering an apoptotic pathway.  
The  ability  to  cleave  epithelial  fodrin  and  thereby  alter  the  cytoskeleton  of  cultured  cells  is 
dependent on the integrity of the serine protease motif of Pet [59,65]. This is in good accordance with 
prior observations that the cytopathic effects of Pet are linked to its serine protease motif [32,46]. The 
collective data from in vitro, cell culture, and organ culture studies support a model in which Pet, by 
virtue of its serine protease activity, cleaves -fodrin. This event inactivates fodrin and consequently 
leads to alterations of the actin cytoskeleton. Cell rounding, exfoliation, and disruptions to the integrity 
of the epithelial monolayer ensue. Pet may also contribute to pathogenesis by collapsing the microvilli 
of intoxicated cells and generating an apoptotic response.  
Like Pet, EspC cleaves GST-fodrin in a reaction that requires a functional serine protease motif 
[45].  However,  unlike  Pet,  fodrin  proteolysis  by  EspC  generates  four  subproducts  with  apparent 
molecular masses of 72, 43, 45, and 34 kDa. The last two fragments come from further processing of 
an initial fodrin proteolytic fragment of around 72 kDa; suggesting two cleavage sites: fodrin's 11th 
and 9th repetitive units (Figure 1). The recognition of separate fodrin proteolytic sites by Pet and EspC 
was further emphasized by competition studies using the inactive Pet S260I and EspC S256I mutant  
toxins [45]. These non-functional toxins are able to enter epithelial cells but are unable to cleave fodrin 
or damage the actin cytoskeleton. An excess of EspC S256I blocked the cytoskeletal damage caused 
by wild-type EspC, but it did not block the cytoskeletal damage caused by Pet. Moreover, an excess of 
Pet  S260I  did  not  prevent  the  cytoskeletal  damage  caused  by  wild-type  EspC.  The  inhibition  of  
wild-type EspC by EspC S256I could not result from competition for surface binding sites, as purified 
EspC  enters  cultured  cells  by  a  pinocytic  mechanism  that  does  not  involve  a  specific  surface  
receptor  [48].  Thus,  the  inhibition  of  wild-type  EspC  by  EspC  S256I  was  most  likely  due  to 
competition for the fodrin binding/proteolysis site. The lack of competition between Pet and EspC 
consequently indicated that the two toxins bind to separate regions of fodrin. These data collectively 
demonstrated that Pet and EspC recognize different binding and cleavage sites in fodrin.  
The distinct patterns of fodrin proteolysis by Pet and EspC result in distinct cellular effects. Both 
toxins  generate  cytopathic  and  enterotoxic  effects  through  disruption  of  the  actin  cytoskeleton. 
However,  fodrin  degradation  by  EspC  is  not  accompanied  by  redistribution  of  the  proteolytic 
fragments to membrane blebs [45]. Furthermore, the fodrin proteolytic fragments generated by EspC 
do  not  correspond  to  the  120  kDa  breakdown  product  resulting  from  Pet  activity  against  the 
calmodulin-binding  domain  of  fodrin  [59,65].  EspC  cleavage  sites  occur  outside  of  the  
calmodulin-bindng domain, although one cleavage site is close to this domain. Since calmodulin and 
calpain I coordinately regulate the interaction between fodrin and filamentous actin to maintain the 
cytoskeletal  integrity  [67],  the  fact  that  Pet  but  not  EspC  cleaves  within  the  calmodulin-binding 
domain of fodrin is perhaps related to the different cellular effects elicited by the two toxins. The Toxins 2010, 2                         
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cleavage  of  fodrin  by  calcium-dependent  proteases  has  also  been  observed  in  several  cellular 
processes, and this proteolysis can lead to various necrotic and apoptotic events [68]. Calpain and 
caspase-3  both  cleave  fodrin  at  adjacent  sites  near  the  calmodulin-binding  domain  in  the  11th 
repetitive unit to generate distinct 150 kDa breakdown subproducts: calpain cleaves between V
1176 and 
G
1177,  while  caspase-3  cleaves  between  D
1185  and  S
1186.  Calpain  subsequently  cleaves  the  fodrin 
proteolytic  fragment  again,  between  G
1230  and  S
1231,  to  produce  a  slightly  smaller  breakdown 
subproduct  of  145  kDa.  In  addition,  caspase-3  cleaves  fodrin  within  the  13th  repetitive  subunit, 
between D
1478 and S
1479, to produce the apoptosis-specific breakdown subproduct of 120 kDa [68]. In a 
similar manner, the differential cleavage of fodrin by Pet and EspC could trigger different biological 
events in addition to the shared disruption of filamentous actin. 
Figure 1. Structure, secretion mechanism, cytoplasm translocation and interaction with the 
protein target of Pet and EspC. (Circle A) Structure and secretion of Pet and EspC through 
the type V secretion system (T5SS). The left cell shows Pet endocytosis and retrograde 
trafficking to reach its intracellular target. The right cell shows EspC translocation through 
the  cooperation  of  the  T5SS  and  the  type  III  secretion  system  (circle  B).  (Circle  C) 
Different cleavage sites for Pet and EspC on fodrin, a common intracellular target. 
 
 
It is clear that EspC and Pet have different activities on epithelial cells, and further studies are in 
progress to  understand the  links  between  EspC,  fodrin  proteolysis,  and  EPEC  pathogenesis.  Even 
though both EspC and Pet have the same serine protease motif belonging to the SPATE subfamily, it is 
clear that the overall conformation of the toxin can influence its specific interaction with the target 
protein.  The  differences  between  EspC  and  Pet  suggest  a  specialized  role  for  EspC  in  EPEC 
pathogenesis which may be different than the role of Pet in EAEC pathogenesis. 
7. Summary 
Pet and EspC are SPATE enterotoxins produced by diarrheagenic EAEC and EPEC, respectively. 
The two toxins are highly homologous and share the same fodrin target. Proteolysis of fodrin disrupts 
the organization of the actin cytoskeleton, so both toxins produce cytopathic and enterotoxic effects. Toxins 2010, 2                         
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Despite these similarities, Pet and EspC exhibit distinct interactions with the host cell. Pet is secreted 
into the medium, enters the target cell by receptor-mediated endocytosis, escapes the endomembrane 
system to enter the cytosol, and cleaves fodrin at a single site between residues M
1198 and V
1199. EspC 
is also initially secreted into the medium, but it is captured by EPEC and injected into the host cell 
cytosol through a type III secretion system. Cytosolic EspC then cleaves fodrin at two sites that are 
separate from the Pet proteolytic site. Continued work on Pet and EspC should help decipher how the 
different  host-pathogen  interactions  for  these two  toxins contribute  to  the  distinct  pathogenesis  of 
EAEC and EPEC. 
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